Imran Hamid, Investment Director at LifeArc Ventures, congratulates portfolio company, Ikarovec, on their successful seed round extension raising a total of £8 million
Imran Hamid, Investment Director at LifeArc Ventures, said:
“Congratulations to our portfolio company Ikarovec on successfully extending their seed funding to £8m, helping to advance their novel gene therapy programme IKC159V towards clinical trials in geographic atrophy (GA), which causes sight loss in millions of people and often acts as a precursor to wet age-related macular degeneration. LifeArc Ventures is proud to support this financing, working alongside Parkwalk Capital and UKI2S.”
